Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 5INDUSTRY 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 4Adenoma 4Polyps 3Neoplasms 3Colonic Polyps 3Adenomatous Polyps 2Triple Negative Breast Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Irritable Bowel Syndrome 1Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 133Gemcitabine 101Paclitaxel 100Carboplatin 84Nivolumab 65Docetaxel 62Bevacizumab 62Cisplatin 57Pemetrexed 50Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 30Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Rituximab 22Prednisone 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × Colonoscopy × Clear all
NCT04638751 2024-04-05

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Persephone Biosciences

Unknown
5,000 enrolled
BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02893748 2019-09-23

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

HyGIeaCare, Inc.

Phase NA Withdrawn

Neoplasms, Polyps

NCT02926209 2019-07-16

Post Market Evaluation of Aer-O-Scope Visualization

GI View Ltd.

Phase NA Terminated
104 enrolled 5 charts

Adenoma, Neoplasms, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡